Annette Raskov Kodahl

Medicin og biovidenskab

1. Breast Neoplasms 100%
2. SARS Virus 42%
3. MicroRNAs 36%
4. Circulating MicroRNA 31%
5. Cohort Studies 30%
6. Fluorodeoxyglucose F18 29%
7. ribociclib 25%
8. Neoplasms 20%
9. Circulating Tumor DNA 20%
10. Tomography 19%
11. Early Detection of Cancer 17%
12. Biomarkers 17%
13. Neoadjuvant Therapy 16%
14. Estrogen Receptors 16%
15. Survival 15%
16. Mammography 15%
17. Physiologic Monitoring 15%
18. Recurrence 14%
19. Infections 13%
20. Positron-Emission Tomography 13%
21. Cost-Benefit Analysis 12%
22. Therapeutics 11%
23. Denmark 11%
24. Case-Control Studies 11%
25. Chromosomes 11%
26. Mortality 10%
27. Retrospective Studies 10%
28. Clinical Trials 10%
29. Serum 9%
30. Comorbidity 9%
31. Disease-Free Survival 9%
32. Coronavirus 7%
33. Endometrial Neoplasms 7%
34. University Hospitals 7%
35. Mutation 6%
36. Uterine Cervical Neoplasms 6%
37. Ovarian Neoplasms 6%
38. Costs and Cost Analysis 6%
39. Pharmaceutical Preparations 5%
40. Epidemiology 5%
41. Survival Rate 5%
42. Datasets 5%
43. Severe Acute Respiratory Syndrome 5%
44. Guidelines 5%